Brief: Invivyd Provides Pemgarda™ Launch Update And Announces 2024 Net Product Revenue Guidance In The Range Of $150 Mln To $200 Mln
04/04/2024 21:29
April 4 (Reuters) - Invivyd Inc IVVD.O :
* INVIVYD PROVIDES PEMGARDA™ LAUNCH UPDATE AND ANNOUNCES
2024 NET
PRODUCT REVENUE GUIDANCE IN THE RANGE OF $150 MILLION TO $200
MILLION
* INVIVYD INC - EXPECTS TO END 2024 WITH AT LEAST $55
MILLION IN
CASH AND CASH EQUIVALENTS
* INVIVYD -PEMGARDA COMMERCIALLY AVAILABLE IN US FOR
PRE-EXPOSURE
PROPHYLAXIS OF COVID-19 IN ADULTS,ADOLESCENTS WITH
MODERATE-TO-SEVERE IMMUNE COMPROMISE
Source text for Eikon: ID:nGNX8THS3D
Further company coverage: IVVD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Invivyd
See all newsBrief: Invivyd Announces Positive Topline Results From Liberty Phase 3 Study Demonstrating Vyd2311 Safety And Tolerability Superior To Mrna-Based Covid-19 Vaccine Announces Regulatory Submission Plans For Vyd2311
Invivyd, Inc. reports results for the quarter ended June 30 - Earnings Summary
Invivyd Q2 loss per share comes wider than expected on higher costs
Brief: Invivyd Q2 EPS USD -0.14
Invivyd, Inc. expected to post a loss of 11 cents a share - Earnings Preview